Skip to content

Gyre Therapeutics, Inc. GYRE Gyre — Cost of Goods Sold

Other segment segments

Gyre Pharmaceuticals
$1.23M+37.2%
All Other Segments
$0

Similar metrics at other companies

AAR Corp logo
AIRProduct — Cost of Goods Sold
$440.2M+32.6%
Winmark logo
WINAProduct — Cost of Goods Sold
$618.5K-30.4%
Neogen logo
NEOGProduct — Cost of Goods Sold
$96M+0.2%
FuelCell Energy logo
FCELProduct — Cost of Goods Sold
$20.28M+24.7%
Innoviva, Inc. logo
INVAProduct — Cost of Goods Sold
$15.61M+76.5%
Opko Health logo
OPKProduct — Cost of Goods Sold
$22.3M-2.3%

Other financials

Income statement

See full
Revenue$22.5M+2.1%
Gross profit$21.3M+0.6%
Operating income-$9.4M-512%
Net income-$8.7M-422%
EPS (diluted)-$0.10

Balance sheet

See full
Cash & equivalents$37.5M+149%
Total debt$823.0K-48.1%
Total equity$101.3M+48.7%
Total assets$162.0M+24.8%

Cash flow

See full
Operating cash flow$3.2M+2,565%
CapEx$178.0K+45.9%
Free cash flow$3.0M+1,296%

Valuation

See full
Market cap$694.58M-4.7%
Enterprise value$657.9M-8.0%
P/S5.9×-1.3×

Profitability

See full
Gross margin95.1%-1.1pp
Operating margin-0.1%-10.4pp
Net margin6.3%+3.3pp
FCF margin2.6%

Returns & leverage

See full
Return on equity8.2%+4.2pp
Debt / equity0.0×
Current ratio4.6×+1.0×

Where this comes from

Reported directly by Gyre Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.

The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gyre Therapeutics, Inc.'s gyre — cost of goods sold.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Gyre Therapeutics, Inc.'s gyre — cost of goods sold?
Gyre Therapeutics, Inc. (GYRE) reported gyre — cost of goods sold of $0 in Q1 2026.
What does gyre — cost of goods sold mean?
This metric captures the direct costs attributable to the production of goods or the delivery of services within the specific business segment. It includes expenses such as raw materials, direct labor, and manufacturing overhead directly linked to revenue generation. Analyzing this helps evaluate the segment's production efficiency and gross margin potential.